Pharmacons ApS: Financial statements 2024
CVR: 36892870
Source: annual report 2024, Danish Business Authority
01/05/2023 – 30/04/2024
Pharmacons ApS (CVR 36892870) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -17,821 and a net result of DKK -18,480 compared with DKK -61,739 the year before. Equity in the 2024 report amounted to DKK 63,032. The solvency ratio was 75%.
- Gross Profit
- DKK -17,821
- Profit/Loss
- DKK -18,480
- Equity
- DKK 63,032
- Total Assets
- DKK 84,008
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -18 t. | -18 t. | 63 t. | - |
| 2023 | - | -61 t. | -62 t. | 82 t. | - |
| 2022 | - | -11 t. | -9 t. | 143 t. | - |
| 2021 | - | -40 t. | -32 t. | 152 t. | - |
| 2020 | - | 22 t. | 20 t. | 184 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Pharmacons ApS
Pharmacons ApS was a Danish company of the type Anpartsselskab based in Helsingør, founded in 2015. The company has been dissolved on 26 May 2025. The company was registered under the industry Anden teknisk rådgivning. The company has 0 employees (2018). In 2024, the company reported a gross profit of DKK -17,821 and a net result of DKK -18,480 compared with DKK -61,739 the year before. Equity in the 2024 report amounted to DKK 63,032.